Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Lili WuYi LuanYa LiMin WangJialin HeChongying JinWenbin ZhangPublished in: BMC cardiovascular disorders (2020)
http://www.chictr.org.cn, Chinese Clinical Trial Registry (ChiCTR1800017876). Registered on 19 Aug 2018.
Keyphrases
- left ventricular
- coronary artery disease
- clinical trial
- heart failure
- aortic stenosis
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- acute myocardial infarction
- lymph node metastasis
- left atrial
- percutaneous coronary intervention
- phase ii
- mitral valve
- coronary artery bypass grafting
- cardiovascular events
- open label
- study protocol
- double blind
- catheter ablation
- type diabetes
- cardiovascular disease
- randomized controlled trial